Shares of Opexa Therapeutics (NASDAQ:OPXA) now have an Average Brokerage Recommendation of 3, number of Recs in ABR is 3 while industry rank of the company by ABR is out of 265.
The volume of the particular stock is the shares bought and sold in a single trading day. To measure price-variation, we found OPXA's volatility during a week at 32.85% and during a month it has been found around 16.7%. Equity research analysts have forecasted the stock level.
Opexa Therapeutics, Inc. (OPXA) has a market capitalization of 7.73 Million which suggests the company is a huge company further suggesting that the shares of Opexa Therapeutics, Inc.
Analysts' ultimate objective when projecting revenue is to determine the appropriate value for a stock. (NASDAQ:OPXA) now have an ABR of 3.00.which is marked on a basic 1 to 5 scale, where 1 stands for a Strong Buy and 5 represents Strong Sell.
Opexa Therapeutics, Inc. (NASDAQ:OPXA) stock is experiencing unusual volume during today's trading.
Group Robs, Sexually Assaults Woman Leaving Church in Queens
They allegedly led her back down the block to 150th Street and Beaver Road where they attacked her behind a garbage truck. An innocent woman, suddenly the victim of a sickening crime. "The shock was too much for her", the friend told The News.
The difference of 52 week low value as well as 52 week high value and the current price of the stock suggests the next move of the shares.
08/12/2016 - Opexa Therapeutics, Inc. had its " rating reiterated by analysts at Aegis Capital.
A stock rating usually tells investors how well a stock's market value relates to what analysts think is a fair value for the stock, based on an independent evaluation of the company. For the week, the stock is performing 58.26%. (NASDAQ:OPXA) jumped 29.27% to hit $1.01.
The stock is now showing YTD performance of 9.78 Percent.
While taking a glance at financials, we can look at a number of key indicators.
Ben Stokes gives Alastair Cook taste of new order
Investec is the title sponsor of Test match cricket in England. It is very different to being captain. Or something like that, anyway.
Management effectiveness shows return on equity and return on assets for the trailing twelve months at -136.97% and -48.56% respectively. The company now has a Return on Equity of -177.6% and a Return on Investment of -296%.
While having a peek at profitability ratios Opexa Therapeutics (NASDAQ:OPXA) has trailing twelve month gross margin at 0%, its trailing twelve month operating margin stands at 0% whereas its trailing twelve month net profit margin spots at 0%. (OPXA) now has a value of $1.01 while the company's 52 week low is at $0.50, the shares dropped to the 52 week low on 11/09/16. While in the same Quarter Previous year, the Actual EPS was $-0.3. Opexa Therapeutics (NASDAQ:OPXA)'s price to free cash flow for trailing twelve months is 0.
During the trading day, the stock price fluctuated between $0.81 and $1.09. Total debt to equity ratio of the company for most recent quarter is 0 whereas long term debt to equity ratio for most recent quarter is 0.
1 analysts on average are expecting the company to report revenue of $0 for the current quarter.
Robinson Cano home run wins All-Star Game for American League
He sent a hanging curve off the back wall of the right-field bullpen, then blew a bubble with his gum when rounding the bases. Perez, now a Marlins executive, was among eight Latin-born Hall of Famers who threw out ceremonial first pitches .
- Founding Families Buy Back Strack & Van Til
- Jay Z's '4:44' goes platinum but absent from Billboard chart
- NewFocus Financial Group LLC Buys 183 Shares of Lowe's Companies, Inc. (LOW)
- Capital One Financial Corporation (COF) Receives Underperform Rating from CIBC
- Bayern Munich signing James Rodriguez open to Real Madrid return
- Bernstein Lowers Devon Energy Corporation (DVN) to Market Perform
- Sports Direct buys 26% stake in Game Digital
- RSP Permian, Inc. (NYSE:RSPP) Director Sells $1351140.00 in Stock
- Don't miss! All the Bollywood stars travelling to NY for IIFA
- PlayStation 5 Predicted to Release in 2019